Drugs affecting HbA1c levels
Glycated hemoglobin (HbA1c) is an important indicator of glycemic control in diabetes mellitus, based on which important diagnostic and therapeutic decisions are routinely made. However, there are several situations in which the level of HbA1c may not faithfully reflect the glycemic control in a giv...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
| Series: | Indian Journal of Endocrinology and Metabolism |
| Subjects: | |
| Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=4;spage=528;epage=531;aulast=Unnikrishnan |
| _version_ | 1817984792343347200 |
|---|---|
| author | Ranjit Unnikrishnan Ranjit Mohan Anjana Viswanathan Mohan |
| author_facet | Ranjit Unnikrishnan Ranjit Mohan Anjana Viswanathan Mohan |
| author_sort | Ranjit Unnikrishnan |
| collection | DOAJ |
| description | Glycated hemoglobin (HbA1c) is an important indicator of glycemic control in diabetes mellitus, based on which important diagnostic and therapeutic decisions are routinely made. However, there are several situations in which the level of HbA1c may not faithfully reflect the glycemic control in a given patient. Important among these is the use of certain non-diabetic medications, which can affect the HbA1c levels in different ways. This review focuses on the non-diabetic medications which can inappropriately raise or lower the HbA1c levels, and the postulated mechanisms for the same. |
| first_indexed | 2024-04-13T23:49:39Z |
| format | Article |
| id | doaj.art-32b8ae5d0fa94472b6b8adb288043cc8 |
| institution | Directory Open Access Journal |
| issn | 2230-8210 2230-9500 |
| language | English |
| last_indexed | 2024-04-13T23:49:39Z |
| publishDate | 2012-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Endocrinology and Metabolism |
| spelling | doaj.art-32b8ae5d0fa94472b6b8adb288043cc82022-12-22T02:24:09ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002012-01-0116452853110.4103/2230-8210.98004Drugs affecting HbA1c levelsRanjit UnnikrishnanRanjit Mohan AnjanaViswanathan MohanGlycated hemoglobin (HbA1c) is an important indicator of glycemic control in diabetes mellitus, based on which important diagnostic and therapeutic decisions are routinely made. However, there are several situations in which the level of HbA1c may not faithfully reflect the glycemic control in a given patient. Important among these is the use of certain non-diabetic medications, which can affect the HbA1c levels in different ways. This review focuses on the non-diabetic medications which can inappropriately raise or lower the HbA1c levels, and the postulated mechanisms for the same.http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=4;spage=528;epage=531;aulast=UnnikrishnanDapsonediabetesglycated hemoglobin |
| spellingShingle | Ranjit Unnikrishnan Ranjit Mohan Anjana Viswanathan Mohan Drugs affecting HbA1c levels Indian Journal of Endocrinology and Metabolism Dapsone diabetes glycated hemoglobin |
| title | Drugs affecting HbA1c levels |
| title_full | Drugs affecting HbA1c levels |
| title_fullStr | Drugs affecting HbA1c levels |
| title_full_unstemmed | Drugs affecting HbA1c levels |
| title_short | Drugs affecting HbA1c levels |
| title_sort | drugs affecting hba1c levels |
| topic | Dapsone diabetes glycated hemoglobin |
| url | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=4;spage=528;epage=531;aulast=Unnikrishnan |
| work_keys_str_mv | AT ranjitunnikrishnan drugsaffectinghba1clevels AT ranjitmohananjana drugsaffectinghba1clevels AT viswanathanmohan drugsaffectinghba1clevels |